Statement defines specific solutions for patient-manipulation by “PBMs” and urges continued bipartisan work on this critical issue.
Last week, Health and Human Services (HHS) Secretary Xavier Becerra appeared before the U.S. Senate Appropriations Committee to provide testimony on the FY 2024 Funding Request and Budget Justification of the Department of Health and Human Services.
Traupe brings 30 years of combined experience in CIA and U.S. Marine Corps; will explore current global threats.
96 percent of those 65 and older say it is “very easy” or “somewhat easy” to access pharmacies – making them the most accessible healthcare destination tested in a national poll.
As part of the study, community-based pharmacists and pharmacy teams worked collaboratively to proactively identify and initiate statin therapy for individuals with Type 2 diabetes.
NACDS President and Chief Executive Officer Steven C. Anderson issued the following statement today upon passage of the Pharmacy Benefit Manager Transparency Act (S. 127) by the U.S. Senate Commerce, Science, and Transportation Committee:
Announces updated national, state, and Congressional District polling relevant to priority issues.
The Drug Price Transparency in Medicaid Act will protect patients, pharmacies, and others from middlemen tactics that drive up prescription drug prices.
A recently published NACDS Foundation research project underscores the power of public health and community-based, pharmacy partnerships when it comes to tackling critical health priorities and improving patient health outcomes.
March 1 Forum in Washington, D.C. advances collaborative role of pharmacy; continues momentum of “NACDS 2023” focus on adding value to members’ innovation of health and wellness in the pharmacy and beyond.
